Le Lézard
Classified in: Health
Subjects: PDT, TDS, FVT

CIRCA SCIENTIFIC to Attend Heart Rhythm 2024


CIRCA Focuses on New Technologies at Premier Electrophysiology Event

ENGLEWOOD, Colo., April 22, 2024 /PRNewswire/ -- CIRCA Scientific, Inc., a pioneer in the development of esophageal temperature monitoring, will be attending Heart Rhythm 2024 to showcase the company's latest technologies for Cardiac Electrophysiology. The company will be highlighting its newest innovations in cardiac access and esophageal temperature monitoring.

MATRIX12M Esophageal Temperature Probe provides unprecedented temperature response and esophageal coverage for cardiac ablation procedures. MATRIX12M provides 3x faster response than the market leading S-CATH-M® multi-sensor probe and 25 times faster response than the common single sensor probes currently available.

CardioCurve Steerable Transseptal Sheath provides exceptional sheath response, a unique dual actuator system and improved sheath to dilator transition.

The annual Heart Rhythm meeting is the largest gathering of heart rhythm professionals in the world. This year's meeting will take place May 16 to 19 in Boston, MA. CIRCA will be showcasing its newest technologies in Exhibit 657.

About CIRCA Scientific
Supporting over 400,000 AF procedures in the last 10 years, CIRCA Scientific has been the global leader in Advanced Esophageal Temperature Monitoring Solutions. CIRCA's Esophageal Temperature Monitoring Systems provide physicians with rapid, reliable data to help them avoid excessive heating/cooling of the esophagus during therapeutic procedures performed in the OR or EP Lab. For more information, visit www.circascientific.com and connect with us on Twitter and LinkedIn.

© CIRCA Scientific, Inc., 2023. All rights reserved MATRIX12, CIRCA Scientific, and the CIRCA Scientific logo are trademarks of CIRCA Scientific, Inc. U.S. Patents 9,155,476 B2 and 9,668,655. Other U.S. and foreign patents pending. CAUTION: US law restricts this device to sale by or on the order of a physician. Before use, consult instructions for use supplied with this device for indications, contraindications, side effects, warnings, and precautions.

SOURCE CIRCA Scientific, Inc.


These press releases may also interest you

at 15:25
UroGen Announces Results from ATLAS Showing Robust UGN-102 Durability of Response in New and Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer at AUA 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
New Real-World Study on Retrograde Instillation of JELMYTO® for Treatment of Low-Grade Upper Tract Urothelial Cancer Reports Similar Complete Response Rate and Lower Stricture Rate Compared to OLYMPUS Pivotal Trial
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Celebrate Women's Heart Health Month With Gundry MD Energy Renew
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch and C-RAD sign collaboration agreement
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
Second Opinion Expert Announces OC FERTILITY® + OC BIOGENIX® To Join Its Panel To Provide Expert Second Opinions.
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Robert Galibert Makes a Drug-Free French Connection on Voices for Humanity
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....

More news about Health...


News published on and distributed by: